How To Fix India's Flawed Vaccination Drive??? Pharma Veteran Chandru Chawla Explains https://www.youtube.com/watch?v=CRnoq6afP2s
A masterstroke needed from the PM to accelerate Universal COVID-19 vaccination – A letter to the PM https://www.expresspharma.in/a-masterstroke-needed-from-the-pm-to-accelerate-universal-covid-19-vaccination-a-letter-to-the-pm/
Addressing the demand-supply gap. Prof R Ramakumar has estimated the very immediate needs. One would need to factor in imminent mutating strains and the possible expected risk to the youth and children.
Addressing the distortion in vaccine access due to the recent policy liberalization. The benefits of “one procurer system for universal vaccination” are undeniable
To eliminate barriers to access – technology and connectivity being the most notable though not the only ones
National Task Force for Vaccine Procurement, NTVP, must be set up as an autonomous body by the Government of India, empowered to do the following:
Set the mandate for the “One Procurer” policy – The terms must be set on universal understood norms of compassionate pricing and access and must deal with attempts at “price gouging” firmly.
Set the “quantitative need” for vaccines, considering factors like priority for risk populations, emerging risk factors such as mutant variants and need for booster doses, etc. guided by the Scientific horsepower in its member body.
Negotiate with both Serum Institute of India and Bharat Biotech in a manner that ensures transparency, balances need for supply urgency without mercenary pressure, helping debottleneck “prioritization of national v/s international commitments” as well as their internal supply chain constraints, with calibrated diversification of supply sources
Set the terms for Compulsory licensing of the Bharat Biotech vaccine, which was developed using Indian taxpayer money, and engineer the transfer of its know-how to other sites in India where capabilities for upstream, downstream, formulation and fill-finish value addition exist. There are possibly half a dozen Indian sites at the bare minimum that can absorb this know-how and get to commercial scale in record time.
Negotiate with alternate sites using creative solutions such as leasing, pay for service or paying even “business disruption premium” for sites that need to disrupt existing business commitments to free capacity and capability.
Qualify and negotiate with both Russian and Chinese vaccine suppliers, waiving off geopolitical pressures and considerations.
The NTVP must be funded with at least Rs 70,000 crores
Coronavirus: Facts vs Myths | The gap between two doses of the Covishield COVID-19 vaccine can be increased to 12-16 weeks, a government panel recommended Thursday, according to a report by news agency PTI. https://youtu.be/BThU1LprK2g Karnataka Health Minster Dr Ashwath-narayan tweeted today, "Today, the National Technical Advisory Group on Immunisation (NTAGI), the advisory group on #COVID19 vaccines, recommends increasing the gap between 2 doses of #Covishield to 12-16 weeks.". Is vaccine shortage driving the vaccine policy?
What Is The Science Behind Increasing COVID Vaccine Doses Gap? | Coronavirus Pandemic | CNBC-TV18 https://www.youtube.com/watch?v=Bzuw3eg7Rok
Increased Gap In Covishield Does To 12-16 Weeks: Science Or Vaccine Shortage? | Left, Right & Centre https://www.youtube.com/watch?v=4bxERfCzTX4
https://www.youtube.com/watch?v=0_o8OW0tVsI The ‘Online-Only' Slot Booking on CoWIN Makes Vaccine Inaccessible for Many | The Quint